NCT02748512View on ClinicalTrials.gov

Utilization and Safety of the Mk II Inserter and the Safety of the FAI Insert in Non-Infectious Uveitis

PHASE3CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 23, 2016

Primary Completion Date

August 17, 2017

Study Completion Date

August 17, 2017

Conditions
Non-Infectious Uveitis
Interventions
DRUG

FAI Insert administered using the Mk II inserter

DRUG

FAI Insert administered using the Mk I inserter

Trial Locations (6)

27710

Duke Eye Center, Durham

29456

Charleston Neuroscience Institute, Ladson

44195

Cleveland Clinic Foundation Cole Eye Institute, Cleveland

76012

Texas Retina Associates, Arlington

80909

Retina Consultants of Southern Colorado, PC, Colorado Springs

02451

Massachusetts Eye Research and Surgery Institution / Ocular Immunology & Uveitis Foundation, Waltham

Sponsors
All Listed Sponsors
lead

EyePoint Pharmaceuticals, Inc.

INDUSTRY

NCT02748512 - Utilization and Safety of the Mk II Inserter and the Safety of the FAI Insert in Non-Infectious Uveitis | Biotech Hunter | Biotech Hunter